Chikungunya differential diagnosis

Revision as of 17:06, 6 June 2014 by Gerald Chi (talk | contribs)
Jump to navigation Jump to search

Chikungunya Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Chikungunya from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Chikungunya differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chikungunya differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chikungunya differential diagnosis

CDC on Chikungunya differential diagnosis

Chikungunya differential diagnosis in the news

Blogs on Chikungunya differential diagnosis

Directions to Hospitals Treating Chikungunya

Risk calculators and risk factors for Chikungunya differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2], Alonso Alvarado, M.D. [3]

Overview

  • The differential diagnosis of chikungunya virus infection varies based on place of residence, travel history, and exposures.
  • Dengue and chikungunya viruses are transmitted by the same mosquitoes and have similar clinical features.
  • The two viruses can circulate in the same area and can cause occasional co-infections in the same patient.
  • Chikungunya virus infection is more likely to cause high fever, severe arthralgia, arthritis, rash, and lymphopenia, while dengue virus infection is more likely to cause neutropenia, thrombocytopenia, hemorrhage, shock, and death.
  • It is important to rule out dengue virus infection because proper clinical management of dengue can improve outcome.
  • In addition to dengue, other considerations include leptospirosis, malaria, rickettsia, group A streptococcus, rubella, measles, parvovirus, enteroviruses, adenovirus, other alphavirus infections (e.g., Mayaro, Ross River, Barmah Forest, O’nyong-nyong, and Sindbis viruses), post-infections arthritis, and rheumatologic conditions.

References

Template:WH Template:WS